DOWLING & YAHNKE LLC - STATERA BIOPHARMA INC ownership

STATERA BIOPHARMA INC's ticker is and the CUSIP is 857561104. A total of 36 filers reported holding STATERA BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DOWLING & YAHNKE LLC ownership history of STATERA BIOPHARMA INC
ValueSharesWeighting
Q3 2022$4,000
-50.0%
28,8750.0%0.00%
Q2 2022$8,000
-11.1%
28,8750.0%0.00%
Q1 2022$9,000
-73.5%
28,875
+96.8%
0.00%
-100.0%
Q4 2021$34,0000.0%14,6750.0%0.00%0.0%
Q3 2021$34,00014,6750.00%
Other shareholders
STATERA BIOPHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Bell & Brown Wealth Advisors, LLC 18,313$5,0000.00%
United Capital Management of KS, Inc. 15,000$4,0000.00%
Renaissance Technologies 1,636,235$466,0000.00%
Sandhill Capital Partners LLC 13,570$4,0000.00%
VANGUARD GROUP INC 389,110$111,0000.00%
JANE STREET GROUP, LLC 35,422$10,0000.00%
UBS Group AG 8,553$2,0000.00%
DOWLING & YAHNKE LLC 28,875$8,0000.00%
IFP Advisors, Inc 500$2,0000.00%
TWO SIGMA INVESTMENTS, LP 41,076$12,0000.00%
View complete list of STATERA BIOPHARMA INC shareholders